Medical Technology Investing Is The Specialty Of Jim Plante

James Plante graduated with a degree in Electrical Engineering at..

Medical Technology Investing Is The Specialty Of Jim Plante

James Plante graduated with a degree in Electrical Engineering at Southern Illinois University and has spent over 25 years perfecting his knowledge and success in investment and entrepreneurship in the fields of biotechnology and technology. Now he is a well-known expert with many patents and successful companies invested in. Success leads to more success and this expert has formed a new company to guide others in investing in the technology and biotechnology fields.

First An Entrepreneur

James Plante has started and been a CEO in many successful technology-based companies. He has invested in others. Companies such as E-Band Communications, Beltronics, SmartDrive systems, Pathway Genomics, and others are responsible for medical and technological advances that help thousands of people. The patents earned and advances made in the treatment of diseases and even the mobile communication industry are impressive.

An Investor

Not only did this expert start and help run several companies, he invested in others. Funding is always a problem for biotechnology companies with ideas for advancing medical treatments. Investing in these companies is risky but well worth it when they succeed in bringing their product to the market.

Investing In The Study Of Genetics

Because of family health problems involving kidney disease, this man started Pathway Genetics. This is one company that has made huge advances in finding diseases and health problems by studying a person’s genetic makeup. Affordable genetic testing can save millions of lives now and into the future. When a person is tested for genetic diseases, they can seek treatment earlier and know the probability of passing on those diseases to future children.

This new company received accreditation for their laboratory in CLIA and also CAP. This company offers the largest range of tests in genetics in this new industry. This genetic testing examines a patient’s genomes with the purpose of finding inherited tendencies for heart disease, cancer, obesity, diabetes, and more. With this knowledge, the patient can take steps to avoid these conditions or get earlier treatment.

One area this is especially helpful in is kidney disease and kidney transplant research. Mr. Plante started an additional company focused on this area called The Foundation for Kidney Transplant Research. For more information, go to the website.